Consortium
- Dr sc. Ivana Matić, Senior research associate, leading researcher
- Dr sc. Tatjana Stanojković, Principal research fellow, Head of Laboratory
- Dr sc. Nina Petrović, Senior research associate
- Prof. dr sc. med. Marina Nikitović, Full professor
- Dr sc. Željko Žižak, Principal research fellow
- Dr sc. Irina Besu Žižak, Senior research associate
- Dr sc. Nataša Todorović Raković, Principal research fellow
- Dr sc. Nađa Grozdanić Stanisavljević, Research associate
- Dr sc. med. Vesna Stanković, Research associate
- Doc. Dr sc. med. Milan Žegarac, Assistant professor
- Dr sc. Branislava Gemović, Research associate
- Dr sc. med. Marko Jevrić, Clinical assistant
- Dr sc. med. Marina Popović Krneta, Research assistant
- Dr Katarina Kopčalić, Research assistant
- Ivana Srbljak, Research assistant
- Ivana Pašić, Research assistant
- Dr Jelena Stanić, Junior research assistant
- Maja Petrović, Junior research assistant
- Dr sc. med. Aleksandar Stepanović, Research associate
- Dr Marija Popović Vuković, Research assistant
Institute for Oncology and Radiology of Serbia, established in 1939, is a comprehensive tertiary care cancer center. IORS is a leading national cancer research center in Serbia which provides diagnosis, cancer treatment, supportive and palliative care, education, and basic, translational, clinical, and epidemiological research in the field of oncology. IORS is actively involved in the national plans for the development of oncology in Serbia. Organisational structure of IORS, consisting of Surgical Oncology Clinic, Clinic for Medical Oncology, Clinic for Radiation Oncology, Department for Diagnostic Radiology, Department for Pediatric Oncology, Department of Nuclear Medicine, Department of Pathology, Department for Laboratory Diagnostics, Department of Experimental Oncology and Department for Genetic Counseling for Hereditary Cancers, is one of the its main strengths in the field of cancer diagnosis and treatment and innovative cancer research. Department of Experimental is the basis for scientific research activity.
- Prof. Dr. Marlon Veldwijk, laboratory head, UHEI group leader
- PD Dr. Carsten Herskind
- Prof. Dr. med. Frank Giordano, Director of Radiation Oncology Department
- Dr. Carsten Sticht, research scientist (bioinformatician)
- M.Sc. Ahmad Šami, research scientist (PhD student)
- M.Sc. Tijana Vlatković, research scientist (PhD student)
- Dr. med. Michael Ehmann, Deputy clinician
- Ms. Miriam Bierbaum, laboratory technician
With more than 30 clinics and institutes the Heidelberg University (Germany) offers a broad spectrum of advanced and high standard diagnostic and therapeutic resources and covers almost all fields of clinical medicine. The combination of cutting-edge medical care and excellent research and education enables interdisciplinary state-of-the-art medical treatment and scientific research at University Medical Centre Mannheim, Medical Faculty Mannheim, part of the renowned Heidelberg University and one of the Europe’s leading academic and research institutions.
https://www.umm.uni-heidelberg.de/medical-faculty-mannheim/home
- Prof. dr sc. Siegfried Knasmüller, MUW group leader
- Miroslav Mišík, MSc PhD mgr, Postdoctoral researcher
- Franziska Ferk, Mag., Senior scientist
Medical University of Vienna, Center for Cancer Research (MUW) is one of the most important top-level research institutions in Europe. It represents Europe’s largest hospital, the AKH in Vienna. Research at MUW focuses on Cellular and Molecular Tumor Biology, Applied and Experimental Oncology, Chemical Safety and Cancer Prevention and tumor Progression and Metastasis. These topics deal with the molecular characterization of events leading to cancer formation, progression and metastasis, the development of novel therapeutic concepts, and the research concerning the impact of environmental factors on cancer development.
- Prof. Maja Čemažar, OI LJUBLJANA group leader
- Prof. Gregor Serša
- Dr. Boštjan Markelc
- Dr. Tanja Jesenko
- Dr. Simona Kranjc Brezar
- Dr. Urška Kamenšek
- Dr. MašaOmerzel
- Dr. Tim Božič
- Dr. Živa Pišljar (rođ. Modic)
- Prof. Primož Strojan
- Assist. Prof. Tanja Marinko
- Alma Čerin
- Aleksandar Saša Lazić
Institute of Oncology Ljubljana (OI LJUBLJANA) is a leading health, educational, and research institution in Slovenia. Institute of Oncology Ljubljana which is a Comprehensive Cancer Centre has the Department of Experimental Oncology that performs research work. Pre-clinical and translation studies are performed independently or, in cooperation with OI LJUBLJANA’s clinical departments or other health and research institutions. OI LJUBLJANA is guided by its basic goal: effective translation of knowledge from the multilevel research domain into clinical practice.
- Prof. dr sc. Christopher Talbot, Professor of Radiotherapy Genetics
- Dr Tim Rattay, Associate Professor in Breast Surgery
- Dr Bo Wang, Associate Professor in Statistics
- Professor Huiyu (Joe) Zhou, Professor of Machine Learning
- Dr Adam Webb, Senior research associate
University of Leicester (ULEIC)
is one of the top 20 universities in the UK and in the top 200 worldwide. The university is organised in three colleges, with the College of Life Sciences (CLS) including the medical school and biological sciences departments such Genetics and Genome Biology. The university has a successful programme of cancer research in which it is investing strongly, being a nationally-funded Experimental Cancer Medicine Centre. The university has recognised strengths in data management, health, and biomedical informatics, as recognised by inclusion in the national Health Data Research UK organisation.
